Akelos Inc. is a biopharmaceutical clinical company focused on the translation of innovative science into treatment. The company currently is developing novel non-narcotic drugs for the treatment of neuropathic pain. The goal of Akelos is to address some of today’s most pressing areas of unmet needs.

Biotechnology

Akelos

Akelos' headquarters in New York, NY, United States

Steven R. Fox

Roger Frechette

Michael Levitt

Thomas G. Heffner

Dianna E. Willis

Peter A. Goldstein

Robert Benson

Gareth R. Tibbs

Charles B. Berde

Thomas Daschle

David Warren

The Advisory Team at Akelos Inc. provides expert guidance on the strategic direction of the company's research and development efforts in non-narcotic drugs for neuropathic pain. Comprised of experienced advisors, the team leverages their industry knowledge to assess market trends, evaluate clinical strategies, and enhance collaborative efforts, ensuring that the company's innovative therapies successfully address significant unmet medical needs.

Advisory Team

The Leadership Team at Akelos Inc. is composed of the visionary founders who drive the strategic direction of the company. They are responsible for overseeing the development of innovative non-narcotic treatments for neuropathic pain, ensuring alignment with Akelos' mission to tackle pressing healthcare challenges. This team fosters collaboration, sets research priorities, and champions a culture of innovation to propel the company's growth and success.

Akelos

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Akelos

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Related companies